> 📌 Previous Analysis: [Berkshire Hathaway (BRK.B) Fair Value Reanalysis: Why a $397B Cash Pile and 1.46x Book Value Support a $532 Target](https://mybestinvesting.co.kr/?p=2254)
[2026년 07월 재분석]
When we last revisited Berkshire Hathaway (NYSE: BRK.B) in mid-July 2026, the entire investment case rested on a deceptively simple triangle: a record cash fortress, a negative-cost insurance float, and a book-value multiple sitting near the level where the company has historically defended its own stock with buybacks. Nine days later, with the stock at $495.50 and the second-quarter earnings report now only days away, almost nothing in that triangle has moved — and that, paradoxically, is the most important thing an investor can know heading into the print.
This is a scheduled checkpoint, not an event-driven scramble. Berkshire’s board and management operate on a rhythm measured in years, not quarters, and our review cadence is deliberately tied to the earnings calendar rather than to daily price noise. With the Q2 2026 report expected in early August 2026 — Greg Abel’s second full quarter as chief executive — this is the right moment to re-underwrite the thesis, stress-test the price targets against fresh consensus data, and lay out exactly what would confirm or break the case when the numbers land.
Three things anchor this update. First, the valuation floor is still intact: at roughly 1.47x book value, Berkshire trades inside the zone where repurchase activity historically kicks in, giving the stock a soft support level near its 52-week low of $455. Second, the cash engine keeps compounding quietly — the $397.4 billion hoard reported in Q1 is throwing off close to $12 billion of annualized interest income, which means shareholders are being paid to wait for Abel to deploy it. Third, the market cap has slipped back below $1 trillion to roughly $963 billion, a reminder that the scale anchor which caps Berkshire’s forward compounding is real, and that any base-case return has to be measured in single-digit percentages plus optionality, not the multibaggers of the company’s early decades.
This article re-walks the full investment case for readers meeting the name for the first time — the business model, the industry backdrop, the moat, the financials, and the valuation — and then, in sections 8 through 11, layers on what has changed since our prior coverage, where the stock stands versus our earlier targets, a refreshed valuation, and an updated exit plan for current holders heading into the Q2 print.
—
1. Company Overview
Berkshire Hathaway is not a company in the ordinary sense; it is a permanent capital allocation vehicle wrapped around a collection of wholly owned operating businesses and a large marketable-securities portfolio. It generates money in four distinct ways, and understanding the mix is the key to valuing it correctly.
Insurance underwriting and float. At the center sits the insurance complex — GEICO in auto, Berkshire Hathaway Reinsurance Group in large-scale reinsurance, and Berkshire Hathaway Primary Group in commercial lines. These businesses collect premiums today and pay claims later, and the gap between the two is the float: roughly $177 billion of other people’s money that Berkshire invests for its own account. When underwriting is profitable, the float is better than free — Berkshire is paid to hold it. In Q1 2026, underwriting income continued to run positive, extending a multi-quarter stretch of negative-cost float.
Investment income. The float and the cash pile are invested in a mix of Treasury bills, equities, and a handful of large operating stakes. With the cash hoard near $397 billion and short-term government yields around 3.7%, the interest income alone is approaching a $12 billion annualized run rate. On top of that sit dividends and mark-to-market moves from the equity portfolio, which is still dominated by a small number of large positions.
Wholly owned operating businesses. Below the insurance layer are the crown-jewel operating units: BNSF Railway, one of North America’s largest freight railroads; Berkshire Hathaway Energy (BHE), a regulated utility and renewables platform; and the sprawling Manufacturing, Service and Retailing group that spans everything from Precision Castparts to See’s Candies to the retail auto business. These units produced the bulk of the $11.34 billion of operating earnings in Q1 2026, up roughly 18% year over year.
Realized and unrealized equity gains. Finally, GAAP net income swings wildly because accounting rules force Berkshire to run unrealized gains and losses on its equity book through the income statement. This is why the trailing-twelve-month net income of $72.47 billion and the headline P/E of about 14.8x are close to meaningless as valuation signals — they are dominated by paper marks, not operating reality.
Revenue and Earnings Mix (approximate, latest disclosed)
Segment What it does Role in the earnings mix Insurance — underwriting GEICO, BHRG, Primary Group premiums less claims Positive underwriting income; generates the float Insurance — investment income Interest + dividends on float and cash ~$12B annualized interest run rate BNSF Railway Freight rail across North America Steady, capital-intensive cash generator Berkshire Hathaway Energy Regulated utilities + renewables Rate-base growth, defensive earnings Manufacturing, Service & Retail Industrials, consumer, retail Largest count of operating businesses Equity portfolio marks Unrealized gains/losses on stocks Noise in GAAP net income; ignore for valuation
On market position, Berkshire is among the very largest financial-and-industrial conglomerates in the world by both revenue — roughly $375 billion in trailing sales — and equity base. Ownership is unusual: the dual-class structure (Class A super-voting shares plus the economically equivalent Class B shares most retail investors buy) concentrates voting control, historically with the founder and now transitioning into the Abel era, while institutional holders own a large majority of the float. That governance structure matters because it insulates management from short-term activist pressure — a feature, not a bug, for a company whose entire edge is the ability to act on a decade-long horizon.
—
2. Industry Analysis
Berkshire straddles several industries, but the one that defines its economics is property and casualty (P&C) insurance, layered on top of a capital-allocation function that competes in the market for whole businesses. To value Berkshire you have to understand both the insurance cycle and the peculiar market for permanent capital.
2-1. Market Size & Growth Trajectory
The global P&C insurance market is enormous and steadily growing — measured in the trillions of dollars of annual premiums, with the US alone accounting for well over a trillion dollars of direct premiums written each year. This is a mature, GDP-plus industry: premium growth tends to track nominal economic growth over the long run, with cyclical swings driven by the “hard” and “soft” market phases, where pricing tightens after large loss events and loosens when capital floods back in.
For Berkshire, the addressable opportunity is not merely writing more policies — it is deploying the float those policies generate. The company sits at an unusual intersection: it is simultaneously a large underwriter and one of the largest pools of deployable capital on earth. That means its true “industry” is the market for large-scale capital allocation — buying whole companies, taking concentrated equity stakes, funding infrastructure, and repurchasing its own shares. In an environment of higher-for-longer interest rates, that cash is finally earning a real return, which changes the calculus of holding it.
Where are we in the cycle? Insurance pricing has been firm-to-hardening in several commercial and reinsurance lines, which supports underwriting margins. Meanwhile, the broader deployment cycle for Berkshire’s cash is arguably in an early, cautious phase: management has been a net seller of equities for multiple years, hoarding dry powder rather than chasing a fully valued market. That patience is the industry-cycle bet embedded in the stock — Berkshire is positioned to be the buyer of last resort if valuations dislocate.
2-2. Structural Growth Drivers
Driver 1 — The float compounding machine. The single most durable growth driver is the insurance float and how it is invested. At roughly $177 billion and structurally negative-cost when underwriting runs profitably, the float is a form of permanent, low-cost leverage that no ordinary asset manager can replicate. As premiums grow with the P&C market and Berkshire retains underwriting discipline, the float tends to expand over time, and every dollar of it can be invested at Berkshire’s blended return on capital. In a higher-rate world, the same float thrown into Treasuries and high-quality credit produces far more investment income than it did in the zero-rate decade, mechanically lifting operating earnings even before any new equity bets. This is the quiet, boring engine that compounds book value at a high-single to low-double-digit rate through cycles, and it is the reason Berkshire’s intrinsic value grinds higher almost regardless of what the stock does in any given quarter.
Driver 2 — Cash as a pre-positioned option on dislocation. The record ~$397 billion cash pile is not idle — it is a call option on market stress. Berkshire’s entire history of outsized returns is built on deploying capital aggressively when others are forced to sell: crisis-era financings, distressed acquisitions, and concentrated equity purchases at trough valuations. With cash now earning ~3.7% while it waits, the opportunity cost of patience has collapsed. If credit markets seize, if a large quality business comes up for sale at a reasonable multiple, or if the equity market corrects meaningfully, Berkshire has the balance sheet to write a check that few other entities on the planet could match. That embedded optionality is genuine economic value that never shows up cleanly on the income statement, and it is worth more today, near a market top, than it was during the easy-money years.
Driver 3 — Regulated utility and rail rate-base growth. Beneath the financial engine sit BNSF and Berkshire Hathaway Energy, two capital-intensive platforms with regulated or quasi-regulated economics. BHE in particular has a long runway of rate-base growth as the US electricity grid is rebuilt and expanded to accommodate electrification and, increasingly, data-center and AI-driven power demand. Regulated utilities earn a permitted return on invested capital, so every dollar of approved capital expenditure translates fairly predictably into future earnings. This is slow, defensive, inflation-linked growth — exactly the kind of ballast that lets Berkshire hold a fortress balance sheet without sacrificing all forward compounding. Rail volumes, meanwhile, are levered to industrial activity and provide an efficient-scale toll on the movement of goods across the continent.
2-3. Competitive Landscape
Berkshire has no true peer, because no other entity combines a large primary insurer, a giant reinsurer, regulated infrastructure, an industrial conglomerate, and a concentrated equity portfolio under one permanent-capital roof. The closest comparisons are pieces of the whole.
Company What it competes on Rough scale Key contrast vs. Berkshire Berkshire Hathaway (BRK.B) Float + permanent capital allocation ~$963B market cap Fortress balance sheet, negative-cost float, ~$397B cash Large P&C insurers (e.g. Chubb, Travelers) Pure-play underwriting discipline Tens of billions No comparable investment optionality or scale of float Large asset managers / private capital Fee-based capital allocation Varies Manage other people’s money for fees; Berkshire owns its capital Diversified industrials Operating-business cash flow Varies Lack the insurance float and countercyclical dry powder
The reason Berkshire is better positioned than any single competitor is structural: an ordinary insurer must keep its capital conservative and liquid to satisfy regulators and rating agencies, and an ordinary asset manager earns fees rather than the full return on capital. Berkshire captures both — it underwrites like an insurer and keeps the entire return on the float and cash, with permanent capital that can never be redeemed at the wrong moment. That combination is close to impossible to assemble from scratch today, which is the essence of its moat.
—
3. Economic Moat Analysis
Berkshire’s moat is not a single wall but a set of reinforcing advantages that are unusually resistant to competition and to time.
Moat Type 1: Efficient Scale + Cost-of-Capital Advantage
The most powerful moat is Berkshire’s structurally low cost of capital, driven by negative-cost float and a fortress balance sheet. Because underwriting has run profitably, the ~$177 billion float costs Berkshire less than zero — competitors funding investments with debt or equity face a real, positive cost of capital, while Berkshire is effectively paid to hold its investable capital. On top of that, Berkshire carries a very low leverage profile (debt-to-equity of just 0.20), which earns it a pristine credit standing and lets it act as a lender or acquirer precisely when leveraged competitors are retrenching. This is efficient scale in its purest form: the sheer size of the float and cash means Berkshire can absorb catastrophe risk, write jumbo reinsurance contracts, and fund large deals that smaller players simply cannot underwrite. Concrete evidence sits in the numbers — a 10.49% return on equity produced with only 0.20x debt-to-equity implies a very high unlevered return, because most peers need far more leverage to reach the same ROE.
Moat Type 2: Intangible / Reputational Moat and Deal Flow
Berkshire’s second moat is reputational and nearly impossible to replicate: it is the counterparty of choice for owners of high-quality private businesses who want a permanent home rather than a private-equity flip. Families and founders sell to Berkshire because it does not strip, re-lever, and resell their companies — a promise backed by a multi-decade track record. That reputation generates proprietary deal flow at reasonable prices, bypassing the competitive auctions that compress returns for financial buyers. It also underpins pricing power in insurance: Berkshire’s balance sheet strength lets it write coverage that stressed competitors cannot, and to name its price when capacity is scarce. This intangible moat is why Berkshire can sit on cash for years without feeling forced to overpay — sellers come to it, on its terms.
Moat Durability Assessment
Will these moats hold for the next five to ten years? The float-and-cost-of-capital advantage is highly durable — it is a function of scale and underwriting discipline, both of which are institutionalized rather than dependent on any one person. The reputational moat, however, faces its one genuine test: the leadership transition to Greg Abel. The single largest risk to the moat is not competition but capital allocation drift — a swelling, undeployed cash pile that depresses ROE, or a large acquisition made at an excessive price to “put cash to work.” So far, Abel has extended the disciplined, patient posture of the prior era, buying back only modest amounts of stock and refusing to chase a fully valued market. The counterargument to the durability worry is precisely this continuity: the culture, the decentralized operating model, and the balance-sheet conservatism are structural, not personality-driven. The moat holds as long as management resists the institutional imperative to deploy cash for its own sake — and the evidence through Q1 2026 is that it is resisting.
—
4. Financial Analysis
Berkshire’s financials must be read on two levels: the noisy GAAP surface and the cleaner operating reality underneath.
Revenue and Earnings Trend
Metric (approx., company filings) FY2023 FY2024 TTM (latest) Total revenue ~$364B ~$371B $375.39B GAAP net income (incl. equity marks) ~$96B ~$89B $72.47B Operating earnings (ex-marks) ~$37B ~$47B ~$46B (est.) Insurance float ~$169B ~$174B ~$177B Cash & equivalents ~$168B ~$334B ~$397B
TTM Sales and net income are the authoritative figures from the latest data fetch; prior-year figures are approximate, drawn from company filings, and the GAAP net-income line swings with equity marks rather than operating performance.
The story the table tells is clear once you separate signal from noise. Revenue has crept steadily higher to ~$375 billion, reflecting premium growth, rail and energy throughput, and rising investment income. GAAP net income is volatile — the drop from ~$96B to ~$72B TTM is almost entirely about equity mark-to-market swings, not deteriorating operations. The metric that actually matters — operating earnings — has grown, with Q1 2026 up ~18% year over year to $11.34 billion, driven by underwriting income and the surge in interest income on the cash pile.
Balance Sheet and Cash Flow
This is where Berkshire is in a league of its own. The balance sheet carries roughly $397 billion in cash and equivalents against a debt-to-equity ratio of just 0.20. Shareholders’ equity — the book value that anchors the valuation — is on the order of $655 billion (implied by the ~$963B market cap divided by the 1.47x price-to-book multiple). Free cash flow is robust and recurring, fed by insurance premiums, rail and utility cash generation, and the now-substantial ~$12 billion annualized interest stream. Crucially, Berkshire pays no dividend, so essentially all of that cash flow compounds internally — either reinvested into the operating businesses, deployed into acquisitions and equities, or returned via opportunistic buybacks.
The Margin and Return Picture
Berkshire’s trailing margins — gross ~23.7%, operating ~16.1%, net ~19.3% — are healthy but not the right lens for a holding company; the return on equity of 10.49% is more telling. A ~10.5% ROE at just 0.20x leverage is a genuinely high-quality return, because it is achieved with almost no financial risk. The path forward on returns is not margin expansion in the traditional sense — it is capital deployment: every dollar of the $397 billion cash pile that Abel can invest at a mid-teens return, rather than parking it at 3.7% in T-bills, is direct upside to forward ROE and book-value growth. That gap between the cash’s current yield and Berkshire’s potential deployment return is the single biggest swing factor in the financial model.
—
5. Valuation
Why Price-to-Book, Not P/E
For most companies, the P/E ratio is the default valuation tool. For Berkshire it is actively misleading. The trailing P/E of about 14.8x (price $495.50 ÷ TTM EPS $33.59) is distorted downward because trailing net income is inflated by unrealized equity gains that may reverse next quarter. The forward P/E of roughly 23x (on consensus forward EPS of $21.49, which strips out much of the equity-mark noise) is a cleaner read on normalized operating earnings, but it still misses the value of the cash optionality and the operating businesses’ intrinsic worth. The right anchor for Berkshire has always been book value, because book value approximates the company’s net asset value and grows in lockstep with intrinsic value over time.
Price-to-Book Framework
Berkshire currently trades at 1.47x book value, implying a book value per share of roughly $337 (price $495.50 ÷ 1.47). Historically, the stock has oscillated within a band of roughly 1.2x to 1.6x book, and management has signaled a willingness to repurchase shares aggressively when the multiple compresses toward the lower end — which is exactly why 1.4–1.5x acts as a soft valuation floor. Book value itself compounds at roughly the ROE, near 10.5% annually, tempered slightly because buybacks executed above book value are modestly dilutive to book-value-per-share growth. Projecting book value per share forward roughly 12 months at that pace lands near $358–$362.
Applying the historical multiple band to forward book value produces the scenario set below:
– Base case — 1.50x forward book (~$358): ≈ $535
– Bull case — 1.62x forward book (~$362): ≈ $588
– Bear case — 1.34x current book (~$337): ≈ $455 (near the 52-week low and the buyback-support zone)
Scenario Analysis
Scenario Fair Value vs. Current $495.50 Key assumption Bull ~$588 +18.7% Multiple re-rates toward 1.62x on a large, accretive cash deployment or hard insurance market Base ~$535 +8.0% Book compounds ~9–10%; multiple holds near 1.50x Bear ~$455 −8.2% Multiple compresses to buyback-support zone amid a market drawdown
Our base-case fair value of ~$535 implies roughly 8% upside from the current price. That is modest — appropriately so for a near-trillion-dollar company — but it comes with a genuine margin of safety, because the bear case is cushioned by the buyback floor and the enormous cash position.
Versus Analyst Consensus
The Street’s consensus 12-month target clusters around $510–$520 — the data-fetch consensus is $509.89, a 10-analyst survey averages roughly $515, and one S&P Global-based read sits near $520. Notably, TD Cowen recently lowered its target to $479 with a Hold rating, reflecting the scale-anchor skepticism. Our base case of $535 sits modestly above the consensus midpoint, and we are comfortable with that gap: consensus tends to underweight the value of the cash optionality and the durability of the book-value floor, focusing instead on the near-term drag of an under-deployed balance sheet. We agree with the Street that upside is single-digit in the base case; we differ in believing the downside is better protected than the average target range implies.
—
6. Risk Factors
Risk 1 — Capital-allocation drift in the Abel era. The defining risk is that the record cash pile becomes a liability rather than an asset. If Greg Abel, under pressure to “do something” with $397 billion, either lets the hoard swell indefinitely — dragging consolidated ROE toward the mid-single digits as low-yielding cash dilutes the operating businesses’ returns — or, worse, deploys it into a large acquisition at a visibly excessive price, the intrinsic-value compounding that underpins the entire thesis breaks. This is the one risk that management controls directly and the one most worth monitoring. The mitigant is the track record through Q1 2026: disciplined, patient, modest buybacks and no reach-for-yield deals. But the leadership transition means the market will demand proof each quarter, and any single ill-judged large deal could re-rate the stock lower and damage the reputational moat simultaneously.
Risk 2 — The scale anchor on forward returns. At roughly $963 billion in market capitalization, Berkshire is simply too large to compound at the rates that made its reputation. The law of large numbers is unforgiving: moving the needle on a $655 billion equity base requires deploying tens of billions into individual opportunities, and there are only a handful of assets in the world large enough to matter. This structurally caps forward returns to a high-single to low-double-digit range in the base case, which means investors expecting multibagger outcomes will be disappointed. For a fortress-balance-sheet ballast holding this is acceptable, but it must be underwritten honestly: Berkshire is a wealth-preservation compounder now, not a wealth-creation rocket, and the valuation upside reflects that.
Risk 3 — Catastrophe and portfolio-concentration volatility. Because Berkshire is both a large reinsurer and the holder of a concentrated equity portfolio, two independent shocks can hit book value at the same time. A major natural-catastrophe year — a large hurricane, earthquake, or wildfire loss — can produce billions in underwriting losses in a single quarter, and Berkshire’s willingness to write jumbo cat reinsurance means it deliberately takes on tail risk that smaller insurers avoid. Simultaneously, the equity book’s concentration in a small number of very large positions means a drawdown in one or two mega-cap holdings can swing GAAP book value materially. Neither is a solvency risk given the fortress balance sheet, but both can pressure the stock and the P/B multiple in the short term, and a coincidence of the two would test the bear-case floor.
—
7. Conclusion & Exit Plan
Investment rating: Hold (core position), accumulate on weakness. Berkshire remains a high-quality ballast holding whose thesis is fully intact heading into Q2 earnings. At $495.50 the stock offers roughly 8% base-case upside plus a well-protected downside — a favorable but unspectacular risk-reward that argues for holding the core position rather than aggressively adding at current levels.
Entry / accumulation range. The most attractive incremental buying zone is $455–$475, near the 52-week low and the historical buyback-support band, and only if underwriting profitability and ROE hold. At those levels the P/B compresses toward the lower end of the historical range, where Berkshire itself becomes a buyer.
Exit conditions:
– Target achieved: Begin trimming into strength — reduce ~30% of the position near the base-case $535, and a further ~25% above the bull-case $588, where the stock would be pricing in aggressive cash deployment that has not yet occurred.
– Fundamental break: Sell if the combined ratio runs above 100% for two or more consecutive quarters, if Abel-era ROE drifts toward the mid-single digits, if a large acquisition is made at a visibly excessive price, or if leverage rises materially above 0.20x debt-to-equity.
– Time-based: Reassess immediately after the Q2 2026 earnings report in early August, with a formal review again in six months.
Item Detail Company Berkshire Hathaway Inc. Class B (BRK.B) Current Price $495.50 Target Price (Base) $535 Upside +8.0% Rating Hold — accumulate $455–$475 Key Thesis Negative-cost float + $397B cash optionality + book-value floor near 1.47x Main Risk Capital-allocation drift under Abel; scale anchor caps forward returns
—
8. What Changed Since Last Analysis
When we first built out the full Berkshire thesis in our June 2026 coverage of Greg Abel’s opening quarter, and reaffirmed it in our mid-July fair-value reanalysis, we argued four core ideas. Nine days on from that reanalysis and with Q2 earnings imminent, here is an honest accounting of where each one stands.
Idea 1 — “The $397 billion cash pile is pre-positioned optionality, and rates keep it productive.” Still valid, arguably strengthening. Nothing has changed to undermine this; if anything, the market’s continued grind higher makes the dry powder more valuable as a hedge against a future dislocation. The cash is still earning close to a $12 billion annualized interest run rate, so shareholders are paid to wait. The open question — will Abel deploy it — remains open, and the Q2 report is the next real data point on the pace of buybacks and any new equity or acquisition activity. We flagged in July that a few billion dollars of Q2 buybacks were plausible; the print will confirm or refute that.
Idea 2 — “The ~$177 billion insurance float is structurally advantaged and negative-cost.” Still valid. Underwriting income was positive and growing in Q1 2026 (operating earnings +18% year over year), keeping the float’s cost below zero. There is no evidence of deterioration, though the Q2 report’s combined-ratio and catastrophe-loss detail is exactly what we will scrutinize — a hurricane-season loss event is the one thing that could dent this leg of the thesis.
Idea 3 — “1.47x book value sits near the buyback-support floor.” Still valid. The stock at $495.50 trades at 1.47x book, essentially unchanged from the 1.46x we cited in July, and remains just above the 52-week low of $455. The valuation floor logic is intact: the closer the multiple drifts to the low-1.4x / high-1.3x zone, the more likely management steps in with repurchases.
Idea 4 — “Book value and operating earnings compound near 10.5% ROE with low leverage, while GAAP net income stays noisy.” Still valid. ROE remains 10.49% and debt-to-equity 0.20, precisely in line with our prior read. The TTM GAAP net income of $72.47 billion continues to be dominated by equity marks and should not be mistaken for operating performance.
New angle since last coverage. The market capitalization has slipped back below $1 trillion to ~$963 billion. This is a subtle but real shift: it modestly improves the forward-return math (a lower starting price for the same intrinsic value) while reinforcing the scale-anchor caution — Berkshire is once again flirting with the psychologically important trillion-dollar line, and the market is clearly debating whether the post-Buffett premium is fully earned.
New/persistent risk to flag. The reanalysis is timed to the review deadline ahead of the Q2 2026 print, and the single largest near-term swing factor is now binary and calendar-driven: the early-August earnings report will reveal Q2 buyback pace, cash-deployment moves, and underwriting margins. Until those land, the thesis is on “confirm or challenge” watch rather than in need of revision.
9. Current Assessment
Measured against our prior analysis point, the stock has barely moved — and that is the honest headline. Our July fair-value reanalysis referenced a price near $490.91; today the stock sits at $495.50, a gain of roughly +0.9% over the nine intervening days. On a longer arc, the position has been a strong performer within a diversified portfolio, but the recent stretch has been a flat, range-bound consolidation between the 52-week low of $455 and the high of $516.85.
None of our prior scenario targets has been reached: the stock remains below the base-case $532 we set in July and well below the bull-case $585, while holding comfortably above the bear-case $452. In other words, it is sitting in the lower-middle of our fair-value range — neither cheap enough to back up the truck nor rich enough to trim.
Time elapsed since our original full coverage in late June is now roughly one month, and since the mid-July reanalysis about nine days. The current holding stance is straightforward: maintaining the core position. The thesis is intact, the valuation is fair, the downside is protected by the buyback floor, and the next catalyst — Q2 earnings — is days away rather than a distant unknown. There is no case for either adding aggressively or trimming at $495.50; the right posture is patience through the print.
10. Revised Price Target & Valuation
We re-ran the price-to-book framework with updated inputs. Because only nine days have passed, the changes are deliberately small — manufacturing large target revisions on a scheduled checkpoint with no new earnings data would be false precision. Book value per share is essentially unchanged at roughly $337, and rolling it forward ~12 months at a ~9–10% compounding rate (net of the mild dilution from above-book buybacks) lands near $358–$362.
Scenario Previous Target (Jul 2026) Revised Target Change Key Driver Base Case $532 $535 +0.6% Forward book ~$358 at 1.50x; continued interest income accretion Bull Case $585 $588 +0.5% 1.62x forward book on accretive cash deployment or hard insurance market Bear Case $452 $455 +0.7% Multiple compresses to ~1.34x book / 52-week-low buyback zone
The nudge higher across all three scenarios is driven by one thing: the steady accretion of book value from operating earnings and the ~$12 billion annualized interest stream over the intervening period, partially offset by the modest dilution of buybacks executed above book. There is no multiple re-rating embedded — we are holding the historical 1.34x–1.62x band constant and simply rolling the book-value base forward.
Against consensus, our revised base case of $535 sits modestly above the Street’s ~$510–$520 cluster (data-fetch consensus $509.89). We continue to disagree gently with the more cautious targets — including TD Cowen’s $479 Hold — because they appear to penalize Berkshire for holding cash without crediting the optionality that cash represents. The bull/bear spread of $455–$588 frames the risk-reward: roughly 8% base-case upside, ~19% in the bull case, and ~8% downside to a floor that Berkshire’s own buyback program is designed to defend.
11. Updated Exit Plan
Recommended stance: continue holding the core position; do not add or trim at $495.50. The stock is fairly valued in the lower-middle of our range, and the imminent Q2 earnings report is the logical decision point.
Scaling plan by price level:
– Accumulate: Add to the position only in the $455–$475 zone, and only if the Q2 report confirms underwriting profitability and a stable-to-improving ROE. That is where the P/B floor and the buyback support align.
– Trim into strength: Reduce roughly 30% of the position near the base-case $535; trim a further ~25% above the bull-case $588, where the stock would be pricing in aggressive, accretive cash deployment that has not yet been demonstrated.
Updated stop-loss / thesis-break triggers. The core thesis is invalidated — and the position should be cut regardless of price — if any of the following occur: the combined ratio runs above 100% for two or more consecutive quarters, signaling the negative-cost float has turned costly; Abel-era ROE drifts toward the mid-single digits, indicating capital-allocation drag; a large acquisition is announced at a visibly excessive price; or leverage rises materially above 0.20x debt-to-equity, eroding the fortress-balance-sheet advantage.
Next review date. The immediate trigger is the Q2 2026 earnings report in early August 2026 — we will reassess buyback pace, cash deployment, and underwriting margins the moment it lands. Absent an earlier surprise, the next scheduled formal review is six months out, in January 2027.
One-sentence summary: For current holders, we recommend maintaining the core Berkshire position through the Q2 print, accumulating only on weakness toward $455–$475, and beginning to trim into strength at $535 and above — the thesis is intact, the downside is defended by the buyback floor, and the near-trillion-dollar scale simply means returns from here are measured in single digits plus optionality, not multiples.
—
Disclaimer:
This content is general investment information provided to an indefinite/unspecified audience by a quasi-investment advisory business registered under Korea’s Financial Investment Services and Capital Markets Act, and is not personalized 1:1 investment advice tailored to any individual investor. This analysis is for informational purposes only and is not a solicitation to invest. All investment decisions and their consequences rest solely with the investor. The estimates and assumptions in this report are as of the writing date (2026-07-27) and may not materialize depending on market conditions and geopolitical variables. Financial data used reflects sources such as company filings and analyst consensus, and the scenarios and price targets represent the author’s conservative assessment. All investments carry the risk of principal loss, and past performance or analytical track record does not guarantee future results. As of the writing date, the author currently holds a position in this stock; this article is a review of an actual position. The author’s holdings and positions may change without prior notice depending on market conditions.
함께 읽으면 좋은 글
- CoStar Group (CSGP) Homes.com Profitability Inflection: Why a 15.6x Forward P/E Near 52-Week Lows Signals 56% Upside
- [2026년 07월 재분석] Microsoft $190 Billion AI Capex Bet: Why the Pullback to a 19x Forward P/E Signals 43% Upside
- [2026년 07월 재분석] Oceaneering International (OII): Record Q2 EBITDA Hit Our $42 Base Target — Why We’re Trimming Into Strength at $48
- First Solar 45X Tax Credit — Full Through 2029, Phasing Down to 2033 — and the AI Data Center Solar Boom: Why FSLR at 8.8x Forward Earnings Offers 24% Upside
- Urban Outfitters Nuuly Subscription Profit Inflection: Why URBN’s 11x Forward P/E Signals 19% Upside to $88